Ophthalmic uses of S1P receptor modulators

Details for Australian Patent Application No. 2010202185 (hide)

Owner Novartis AG

Inventors Latour, Elisabeth Jeanne; Lambrou, George N.

Agent Davies Collison Cave

Pub. Number AU-B-2010202185

Parent 2006222266

Filing date 28 May 2010

Wipo publication date 17 June 2010

Acceptance publication date 14 June 2012

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

17 June 2010 Application Open to Public Inspection

  Published as AU-B-2010202185

17 June 2010 Complete Application Filed

14 June 2012 Application Accepted

  Published as AU-B-2010202185

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202186-Marketing asset exchange

2010202184-Tetherless biopsy device with reusable portion